Mike Schultz @michael-schultz.bsky.social · 04/03/2026Join me on Saturday in Federal Plaza, Chicago to stand up for science! 📍Federal Plaza, 230 S Dearborn St, Chicago, IL 60604 🗓️ Saturday, March 7th, 1pm 🔗 More information and RSVP www.mobilize.us/indivisiblec... 011
Reposted by Mike SchultzAnna Vlasits @annaintegrated.bsky.social · 12/02/2026Hey #chicago! We're joining the national Day of Action on March 7 to Stand Up for Science @standupforscience.bsky.social It's time again to show your support for science in the US! 133
Mike Schultz @michael-schultz.bsky.social · 02/01/2026Very cool paper showing a NAMPT activator that restores NAD+ in the brain can prevent Alzheimer's onset in an amyloid-driven 5xFAD mouse model. More evidence of a metabolic basis for neurodegenerative diseases. www.cell.com/cell-reports...cell.comPharmacologic reversal of advanced Alzheimer’s disease in mice and identification of potential therapeutic nodes in human brainChaubey et al. demonstrate that restoration of brain resilience reverses advanced disease in two different mouse models of Alzheimer’s disease (AD), challenging the century-long dogma of AD irreversib... 082
Reposted by Mike SchultzStand Up for Science! @standupforscience.net · 15/04/2025Tax Day - round 3 - NIH 🩻🧠🧬 🧬 The average U.S. taxpayer contributes $105/year to NIH, helping fund: • Cancer & rare disease breakthroughs • Pandemic preparedness • Children’s health • Medical tech innovation • Mental health science & more NIH powers the science behind the healthcare we rely on. 4328131
Mike Schultz @michael-schultz.bsky.social · 19/03/2025Sustained support for the NIH, NSF, FDA, and other science agenices is what has made American the best place in the world for biomedical innovation. It's important that we preserve it. Watch Portal's John Flavin on CNBC!cnbc.comPortal Innovation's Founder on the impact of NIH funding cuts on long-term drug developmentJohn Flavin, Portal Innovations Founder & CEO, joins 'Fast Money' to talk how NIH funding cuts could be detrimental for the U.S. pharmaceutical industry and drug development. 031
Mike Schultz @michael-schultz.bsky.social · 18/03/2025In light of disruptions to federally-funded science, one program with bipartison support has fallen through the cracks. In December, Congress let the priority review voucher program expire. The PRV program incentives companies to develop drugs for pediatric rare diseases.innoeco.substack.comDon't Put Sick Kids on HoldOn the importance of the rare pediatric disease priority review voucher program 120
Mike Schultz @michael-schultz.bsky.social · 11/03/2025Thank you to the 1,500+ people who battled the wet snow to attend the @standupforscience.bsky.social Chicago rally! If you weren't able to attend, watch the rally here: lnkd.in/gRhwH9nW 1131
Reposted by Mike SchultzIndivisible Chicago Alliance ❌👑 @indivisiblechicago.bsky.social · 08/03/2025Without NIH funding for research, "your mother's cancer will wait for a cure. Your child's genetic disorder will wait for a breakthrough. The research that could save lives may be delayed or never come." ~Melissa Byrn, UChicago @standupforscience.bsky.social #StandUpForScience2025 4453113
Reposted by Mike SchultzIndivisible Chicago Alliance ❌👑 @indivisiblechicago.bsky.social · 07/03/2025If you want a great nation, you don't eliminate research - medical, agricultural, across the board. Research looks into the future and gives us hope. We need to stand together! ~US Senator Dick Durbin @durbin.senate.gov @standupforscience.bsky.social #StandUpForScience2025 15615
Mike Schultz @michael-schultz.bsky.social · 07/03/2025Join us, tomorrow (Friday)! @standupforscience.bsky.social 📍 Federal Plaza, Chicago 🕛 March 7, 2025 | 12 PM 📋 Register: lnkd.in/gguRyePu 🔗 Learn more: standupforscience2025.org 121
Mike Schultz @michael-schultz.bsky.social · 02/03/2025Thank you Chicago Sun-Times for featuring me and some of my co-organizers of Stand Up for Science Chicago. It's critical we advocate for protecting federally-funded science and highlight what's at stake for patients.chicago.suntimes.comChicago scientists reel from Trump funding cuts: 'We are just going to abandon all those discoveries'On Friday, scientists will leave their labs to protest cuts to research in Chicago and across the country. 3309
Mike Schultz @michael-schultz.bsky.social · 24/02/2025I'm helping to organize this. Spread the word. Reach out to me to get involved. 📍 Federal Plaza, Chicago 🕛 March 7, 2025 | 12 PM 🔗 Learn more: standupforscience2025.orgstandupforscience2025.orgSTAND UP FOR SCIENCEMarch 7, 2025. Washington DC and nationwide. Because science is for everyone. 140
Reposted by Mike SchultzStand Up for Science! @standupforscience.net · 12/02/2025Welcome to the Bluesky account for Stand Up for Science 2025! Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide! #scienceforall #sciencenotsilence 289114575402
Mike Schultz @michael-schultz.bsky.social · 13/02/2025The NIH funding crisis has been stressful and potentially damaging to US science. America has the best innovation ecosystem in the world, and for any complex ecosystem, disruption can have cascading effects. Read this piece by my colleague Steven Lehmann on how the innovation landscape might change.innoeco.substack.comNavigating a Shifting Biotech EcosystemThe foundations of the biomedical research are shifting beneath our feet. 010
Reposted by Mike SchultzLaura White @laurakwhite.bsky.social · 09/02/2025There’s no argument that should reassure anyone enough to go back to business as usual, because none of these actions are happening in isolation. The war on US science won’t end with a court order on indirects. 317439
Reposted by Mike SchultzMark Cuban @mcuban.bsky.social · 25/01/2025Speaking of healthcare. Let's make @bsky.app the platform that fights misinformation. Some great follows are @drsusanoliver.bsky.social @jsm2334.bsky.social @therealtruther.bsky.social Let's get them more followers and engagement than other platforms and let health science accounts find a home 36527497214110
Reposted by Mike SchultzJonathan Howard @joho.bsky.social · 27/01/2025This is the former dean of Harvard med school. He defended several pandemic misinformation doctors from “uncivil” tone, while dunking on those of us who tried to sound the alarm about misinformation agents. I tried to warn him and he got furious with me. 511332
Mike Schultz @michael-schultz.bsky.social · 18/12/2024innoeco.substack.com/p/theres-no-...innoeco.substack.comThere's No Such Thing as an Aging CompanyWhy we are investing in the aging space anyway 120
Reposted by Mike SchultzDrew Berry wehi.tv @drewberry.bsky.social · 29/11/2024Happy Holliday Junction for those who celebrate 312128
Reposted by Mike SchultzPrasad Jallepalli, MD, PhD @prasad.bsky.social · 28/11/2024unusual for NIH directors — most have experience in basic, translational, and/or clinical research not to mention records of leading large biomedical research enterprises, pioneering their field of study, and a combination of visibility and service to the research community 0209
Mike Schultz @michael-schultz.bsky.social · 27/11/2024Nice interview from @biotechtv.bsky.social Brad Loncar with CEO Sarah Hein of March Bio, which raised a $28M series A. Portal invested in the seed round. March Bio is making T cells that kill other T cells. www.biotechtv.com/post/march-b...biotechtv.comTexas Life Science Forum: March Biosciences closed a $28.4M series A round last month to advance its CD5 targeting CAR-TCEO Sarah Hein describes the rationale for CD5, and share her experience of what it was like making the raise come together.Sara FullBrought to you by 051
Reposted by Mike SchultzKavita Patel MD @drkavitapatel.bsky.social · 27/11/2024Aside from how horrible this is for public health this might be the only time you will see words like “neocortex” or “mitochondrial mutations” in a statement from Trump 2255
Mike Schultz @michael-schultz.bsky.social · 27/11/2024Poseida acquisition is good news for allogeneic cell therapy companies. www.prnewswire.com/news-release...prnewswire.comPoseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc./PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX) ("Poseida"), a clinical-stage allogeneic cell therapy and genetic medicines company advancing... 110
Mike Schultz @michael-schultz.bsky.social · 24/11/2024I was surprised a Biotech Investor starter pack wasn’t available, so I made one. Please help grow this community. go.bsky.app/GV6usnz 5206
Mike Schultz @michael-schultz.bsky.social · 23/11/2024Earlier this week had had our 2nd ever Portal Innovations book club on Breaking Through, the autobiography of Katalin Karikó who won a Nobel Prize for her work on modified mRNA that enabled the COVID vaccines. 110
Mike Schultz @michael-schultz.bsky.social · 23/11/2024So glad to see a critical mass of a science community here! 🧬🔬🧫 ❌ to X Blue skies ahead! ☀️ 040